Literature DB >> 12408226

Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease.

Dietmar Rudolf Thai1.   

Abstract

The excitatory amino acid transporter EAAT-2 is physiologically expressed in astrocytes. This study demonstrates that distinct subclasses of neurons exhibited EAAT-2 immunoreactivity in cases with Alzheimer's disease (AD). EAAT-2 was identified in the following types of neurons: Cortical pyramidal cells, fascia dentata granule cells, neurons of the basal nucleus of Meynert, the substantia nigra, the paraventricular nucleus of the hypothalamus, oral and central raphe nuclei, locus coeruleus, parabrachial nucleus, and neurons of the reticular formation of the brain stem. All EAAT-2-positive neurons displayed cytoskeletal abnormalities with abnormal tau-protein and often showed condensed and shrunken nuclei. None of the control cases without AD-related pathology showed EAAT-2-immunoreactive neurons. These results indicate that AD-related neurodegeneration is associated with the expression of the glutamate transporter EAAT-2 in altered neurons. Since an aberrant expression of EAAT-1 in neurons has recently been described, the finding of a neuronal expression of EAAT-2 strongly supports the hypothesis that abnormalities in glutamate transport play an important role in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408226

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  15 in total

1.  Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.

Authors:  Randall L Woltjer; Kevin Duerson; Joseph M Fullmer; Paramita Mookherjee; Allison M Ryan; Thomas J Montine; Jeffrey A Kaye; Joseph F Quinn; Lisa Silbert; Deniz Erten-Lyons; James B Leverenz; Thomas D Bird; David V Pow; Kohichi Tanaka; G Stennis Watson; David G Cook
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

2.  Gender-Related Hippocampal Proteomics Study from Young Rats After Chronic Unpredicted Mild Stress Exposure.

Authors:  Lin-Na Ning; Teng Zhang; Jiang Chu; Na Qu; Li Lin; Ying-Yan Fang; Yan Shi; Peng Zeng; Er-Li Cai; Xiao-Ming Wang; Qun Wang; You-Ming Lu; Xin-Wen Zhou; Qi Zhang; Qing Tian
Journal:  Mol Neurobiol       Date:  2017-01-07       Impact factor: 5.590

Review 3.  Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.

Authors:  P M Beart; R D O'Shea
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

4.  Neuronal expression of splice variants of "glial" glutamate transporters in brains afflicted by Alzheimer's disease: unmasking an intrinsic neuronal property.

Authors:  David V Pow; David G Cook
Journal:  Neurochem Res       Date:  2009-03-25       Impact factor: 3.996

Review 5.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 6.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons.

Authors:  Nady Braidy; Hayden Alicajic; David Pow; Jason Smith; Bat-Erdene Jugder; Bruce J Brew; Joseph A Nicolazzo; Gilles J Guillemin
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

Review 8.  Dementia and its implications for public health.

Authors:  Daniel P Chapman; Sheree Marshall Williams; Tara W Strine; Robert F Anda; Margaret J Moore
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

9.  Chronic ethanol exposure produces time- and brain region-dependent changes in gene coexpression networks.

Authors:  Elizabeth A Osterndorff-Kahanek; Howard C Becker; Marcelo F Lopez; Sean P Farris; Gayatri R Tiwari; Yury O Nunez; R Adron Harris; R Dayne Mayfield
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.

Authors:  S M O'Donovan; K Hasselfeld; D Bauer; M Simmons; P Roussos; V Haroutunian; J H Meador-Woodruff; R E McCullumsmith
Journal:  Transl Psychiatry       Date:  2015-06-09       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.